KF
MRNA icon

Krilogy Financial’s Moderna MRNA Stock Holding History

Krilogy Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,671
Closed -$257K – 324
2023
Q1 		$257K Sell
1,671
-165
-9% -$27.2K 0.02% 352
2022
Q4 		$330K Sell
1,836
-2
-0.1% -$327 0.03% 308
2022
Q3 		$217K Sell
1,838
-47
-2% -$7.13K 0.03% 288
2022
Q2 		$269K Sell
1,885
-137
-7% -$19.6K 0.03% 266
2022
Q1 		$348K Sell
2,022
-1,440
-42% -$242K 0.04% 238
2021
Q4 		$879K Sell
3,462
-159
-4% -$46.5K 0.09% 139
2021
Q3 		$1.39M Buy
3,621
+268
+8% +$98.8K 0.14% 105
2021
Q2 		$788K Sell
3,353
-343
-9% -$61.3K 0.08% 149
2021
Q1 		$484K Sell
3,696
-31
-0.8% -$4.49K 0.05% 177
2020
Q4 		$389K Buy
3,727
+382
+11% +$38.6K 0.05% 195
2020
Q3 		$237K Buy
+3,345
New +$233K 0.03% 211

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Krilogy Financial's MRNA Position: Q2 2023 in Review

Krilogy Financial sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,671 shares — an estimated $257K sold.

Krilogy Financial first reported a position in MRNA in Q3 2020 and held it in 11 quarters. The position peaked at $1.39M in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Krilogy Financial reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Krilogy Financial sold 1,671 Moderna shares in Q2 2023, an estimated $257K.
  • Krilogy Financial first reported a position in Moderna in Q3 2020 and held it in 11 quarters.
  • Krilogy Financial's Moderna position peaked at $1.39M in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Krilogy Financial's 13F filing for Q2 2023, filed 19 Jul 2023.